June 01, 2021
Clarus Therapeutics Inc. has convinced a federal judge to invalidate claims in four Lipocine Inc. patents that Clarus was accused of infringing with its testosterone replacement treatment Jatenzo, according to an opinion unsealed Tuesday.
January 05, 2021
The ongoing COVID-19 pandemic has prompted a federal judge to push back the start of a jury trial in Delaware federal court over allegations that a pharmaceutical company's low-testosterone drug infringes patents held by a rival.